Decitabine - Wikipedia

Mechanism. Decitabine is a hypomethylating agent. It hypomethylates DNA by inhibiting DNA methyltransferase. It functions in a similar manner to azacitidine, although ...

Decitabine - Drug Information - Chemocare

Decitabine (Dacogen) chemotherapy side effects, how it's given, how it works, precautions and self care tips for treatment of myelodysplastic syndrome (MDS)

Decitabine: Indications, Side Effects, Warnings - Drugs.com

Easy to read patient leaflet for Decitabine. Includes indications, proper use, special instructions, precautions, and possible side effects.

Decitabine - National Cancer Institute - Comprehensive ...

This page contains brief information about decitabine and a collection of links to more information about the use of this drug, research results, and ongoing clinical ...

Decitabin – Wikipedia

Eintrag zu Decitabine in der Human Metabolome Database (HMDB), abgerufen am 15. November 2013. FDA Label von Dacogen (PDF; 235 kB).

European Medicines Agency - Find medicine - Dacogen

Product details for Dacogen; Name: Dacogen: Agency product number: EMEA/H/C/002221: Active substance: decitabine. International non-proprietary name (INN) or common name

Decitabine - FDA prescribing information, side effects and ...

Decitabine official prescribing information for healthcare professionals. Includes: indications, dosage, adverse reactions, pharmacology and more.

Decitabine Injection: MedlinePlus Drug Information

Decitabine Injection: learn about side effects, dosage, special precautions, and more on MedlinePlus

FDA Approval for Decitabine - National Cancer Institute

Information from the FDA about the approval of this drug and the clinical trials that led to the approval.

Decitabine - Search Livertox Database

Introduction Decitabine is a cytosine analogue and an intravenously administered antineoplastic agent used in the therapy of myelodysplastic syndromes.